Treatment of FIP1L1/PDGFRA-negative hypereosinophilic syndrome with alemtuzumab, an anti-CD52 antibody
Wagner, Lori A., Speckart, Stephen, Cutter, Bruce, Gleich, Gerald J.Volume:
123
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2009.01.069
Date:
June, 2009
File:
PDF, 154 KB
english, 2009